The content on this site is intended for healthcare professionals only
Measuring success in indolent disease: Question and answer session from BSH 2017.
The content available here was filmed at a Roche Products Limited promotional symposium and contains discussion of Roche medicines.
ASCO 2026: Latest updates in mRCC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
